Scopus BioPharma Inc. (SCPS)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
Feb 6, 2026, 9:30 AM EST
Scopus BioPharma Market Cap
Scopus BioPharma has a market cap or net worth of $25.25 thousand as of February 9, 2026. Its market cap has decreased by -98.59% in one year.
Market Cap
25.25K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 16, 2020, Scopus BioPharma's market cap has decreased from 85.70M to 25.25K, a decrease of -99.97%. That is a compound annual growth rate of -79.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 25.25K | 50.00% |
| Dec 31, 2025 | 16.83K | 33.34% |
| Dec 31, 2024 | 12.63K | -99.30% |
| Dec 29, 2023 | 1.81M | -11.91% |
| Dec 30, 2022 | 2.06M | -94.04% |
| Dec 31, 2021 | 34.49M | -83.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mera Pharmaceuticals | 53.67K |
| Nascent Biotech | 51.85K |
| LadRx | 51.24K |
| Itoco | 42.82K |
| Syros Pharmaceuticals | 21.47K |
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |